Page 15 - Bin Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Source: Sundry Photography / Shutterstock.com There is no denying that Chinese electric vehicle maker Nio has already come far. Shares started 2020 below $5 and now trade for nearly $60. The company has blown past concerns it would run out of cash, emerging as an innovative and fast-growing EV leader. So where does the company go next? As one of the top stocks to buy for 2021, many analysts are starting to raise their price targets. JPMorgan analyst Nick Lai just raised his price target to $75, while Credit Suisse analyst Bin Wang raised his to $71. However, InvestorPlace analyst Luke Lango ...

Order Reprints Print Article NIO Day 2021 was a success, at least according to Asia’s equivalent of Wall Street. The Chinese electric vehicle maker hosted its annual consumer event on Saturday, launching a new luxury sedan and talking about other battery and software improvements. Now analysts, mainly based in China and Hong Kong, are raising their price targets.NIO stock (ticker: NIO) closed up about 6.4% Monday to just under $63 a share. Shares are up roughly 1,700% over the past year. The S&P 500, for comparison, finished about 0.7% lower. Monday’s... Close NIO Is Rallyin...

About the INO-4800 "INNOVATE" Phase 2/3 Clinical Trial The lead Principal Investigator for INNOVATE is Dr. Pablo Tebas, Professor of Medicine at the Hospital of the University of Pennsylvania. The Phase 2 segment of the clinical trial is designed to evaluate safety, tolerability and immunogenicity of INO-4800 in a 2-dose regimen (1.0 mg or 2.0 mg), in a three-to-one randomization (in a planned total of 400 subjects) to receive either INO-4800 or placebo, to confirm the more appropriate dosing level for each of three age groups (18-50 years, 51-64 years and 65 years and older) for the subseque...